Message from Partners

We at Starcell Biotech,
Are constantly striving to add value to companies who are committed to adopt new technologies in support of life. And in this journey of providing innovative products and services, we hope to establish affordable healthcare across the globe.

Starcell Biotech laid its foundation in 2017 and since then has supported companies across the globe to adapt new technologies for manufacturing highly complex biosimilar and other pharmaceutical products.

Our aim is to provide innovative technology for manufacturing Biosimilars within reach of Every Company that has the vision and capabilities to do so.

Our corporate Mission, Vision and Core Values form an integral part of our business principles and business strategy. Starcell Biotech is on a mission to provide affordable innovative technology for biosimilars and other pharmaceuticals and here by create contribute to a significant cost reduction of biosimilars drugs.

More than just products and services, Starcell Biotech provides innovative technology in Diabetes care specially from IDDM patients. Since 2017, we have added monoclonal Antibodies (mAB) range of products in our portfolio. Come 2018 and we have extended our portfolio of in Vaccine, Nephrology and Anti-coagulant range fo products and services.

At Starcell Biotech, we will continue to transfer innovative products and services along with affordable technology for Biosimilars which will boost growth of biologics industry and thereby enable companies to provide affordable patient medications.